"Maimonides Medical Center is recognized for clinical excellence and exceptional patient care, with convenient offices throughout Brooklyn."

During the past decade, Maimonides MS Care Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Maimonides MS Care Center" are "Multiple Sclerosis" (3 trials). Many other conditions were trialed in "Maimonides MS Care Center" in a lesser frequency.

Most popular intervention types in "Maimonides MS Care Center" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "10 milligram (mg) fampridine-SR (4-aminopyridine, 4-AP)" (1 trials), "15 mg fampridine-SR (4-aminopyridine, 4-AP)" (1 trials), "20 mg fampridine-SR (4-aminopyridine, 4-AP)" (1 trials), "Fampridine-SR" (1 trials) and "Fampridine-SR b.i.d. (Twice Daily)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Maimonides MS Care Center" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Maimonides MS Care Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Maimonides MS Care Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Maimonides MS Care Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".